Healthcare Sector: Is Happiness Biotech Group Ltd (HAPP) Stock Outperforming or Underperforming?

Wednesday, April 15, 2020 2:08 PM | InvestorsObserver Analysts

Happiness Biotech Group Ltd (HAPP) is near the bottom in its sector according to InvestorsObserver.

HAPP gets an overall rating of 92. That means it scores higher than 92% of stocks.

Happiness Biotech Group Ltd gets a 22 rank in the Healthcare sector. Healthcare is number 2 out of 11 sectors.

Overall Score - 92
HAPP has an Overall Score of 92. Find out what this means to you and get the rest of the rankings on HAPP!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 92 means the stock is more attractive than 92 percent of stocks.

Not only are these scores easy to understand, but it is easy to compare stocks to each other. You can find the best stock in healthcare or look for the sector that has the highest average score.

The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Happiness Biotech Group Ltd Stock Today?

Happiness Biotech Group Ltd (HAPP) stock has risen 3.42% while the S&P 500 is lower by -2.79% as of 1:59 PM on Wednesday, Apr 15. HAPP has gained $0.11 from the previous closing price of $3.22 on volume of 656,963 shares. Over the past year the S&P 500 is lower by -8.46% while HAPP is lower by -26.00%. HAPP earned $0.83 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 4.02.

To see InvestorsObserver's Sentiment Score for HAPP click here.

Share this article:

Related Companies

Upgrade to Premium and Analyze Stocks Like a Pro

40% Off All Subscriptions
InvestorsObserver Premium
InvestorsObserver Premium
InvestorsObserver Premium
Save up to 57% with annual

InvestorsObserver Premium

$ 20.75 $ 12.45 /month
$249 $149.40 billed annually

You May Also Like

Related Articles

Related Companies